Successful response of upadacitinib in the treatment of atopic dermatitis lesions involving sensitive and visible areas resistant to dupilumab.
Sign Up to like & getrecommendations! Published in 2023 at "Clinical and experimental dermatology"
DOI: 10.1093/ced/llad040
Abstract: Beneficial effects of upadacitinib in the treatment of atopic dermatitis (AD) patients who resulted unresponsive to dupilumab therapy have been described. AD lesions resistant to dupilumab and localized in sensitive and visible areas showed a… read more here.
Keywords: upadacitinib treatment; treatment atopic; sensitive visible; visible areas ... See more keywords